首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Future oncology

缩写:FUTURE ONCOL

ISSN:1479-6694

e-ISSN:1744-8301

IF/分区:2.6/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引5147
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zining Liu,Zhening Zhang,Hua Liu et al. Zining Liu et al.
Aim: The authors conducted a meta-analysis to determine the association between time-to-surgery (TTS) after neoadjuvant chemotherapy and patient outcomes in locally advanced gastric cancer. Methods: Electronic databases were searched to ide...
Haitham Shaheen,Mohamed S Zaghloul,Hany Ammar et al. Haitham Shaheen et al.
Background: Deep inspiration breath-hold (DIBH) has been established to decrease normal tissue radiation dose in breast cancer. Methods: Forty-nine patients had two CT scans during DIBH or free breathing. Chest-wall position, setup verifica...
Honggang Guo,Mingyue Shi Honggang Guo
Aim: Blastic plasmacytoid dendritic cell neoplasm is a rarely occurring hematologic malignancy with a dismal prognosis. Methods: We conducted a meta-analysis for a total of 1312 patients from 24 retrospective studies. Results: The complete ...
Aleena Malik,Meghan P Jairam,Ronald Chow et al. Aleena Malik et al.
Aim: The aim of this meta-regression was to assess the impact of mean/median age, mean/median tumor size, percentage of males in total sample, and total sample size on the comparative effectiveness of radiofrequency ablation (RFA) and stere...
Pengjie Yu,Shengmao Zhu,Yongqiang Pu et al. Pengjie Yu et al.
Aim: To explore the efficacy and safety of paclitaxel+oxaliplatin+S-1 (PSOX), docetaxel+oxaliplatin+fluorouracil (DOF) and oxaliplatin+S-1 (SOX) regimens as neoadjuvant chemotherapy for advanced gastric cancer (GC). Methods: A retrospective...
Charles Dharmani,Eric Wang,Nora Tu et al. Charles Dharmani et al.
Background: Without treatment, acute myeloid leukemia (AML) is rapidly fatal. Nevertheless, a large proportion of elderly AML patients do not receive any treatment. Aim: To characterize the demographics, comorbidities, survival and prognost...
Sharmeen Mahmood,Daneng Li,Arielle Lee et al. Sharmeen Mahmood et al.
Durvalumab, a PD-L1 inhibitor, is part of an immunotherapeutic drug class shown to have prolonged survival benefit in patients with advanced stage hepatocellular carcinoma (HCC). Tivozanib is a potent and selective VEGFR 1, 2 and 3 tyrosine...